CDKN2B-AS1 and coronary artery disorder: Consistent with our finding of the causal role of ANRIL in atherosclerosis, genetic variants of TMEM106B significantly increased the risk of CAD and interacted with ANRIL variants to confer an epistatic effect on risk of CAD (31).